Due to transition in the journal platform, the previously submitted articles, which are under process can be re-submitted here for quick process, kindly co-operate

Biomedicine

Volume: 43 Issue: 2

  • Open Access
  • Original Article

Plasma homocysteine, serum vitamin B12 and folic acid status in newly detected schizophrenic patients of eastern India

Neelam Mehta1, Itishri Jena2, Subhashree Ray2, Sudeshna Behera2, Subrat Kumar Tripathy2, Sarthak Ranjan Nayak2, Bratati Singh2

1Department of Pathology, TATA Main hospital, Jamshedpur, 831 001, Jharkhand, India
2Department of Biochemistry, IMS & SUM Hospital, Bhubaneswar, 751 003, Odisha, India

Corresponding author: Itishri Jena. Email: [email protected]

Year: 2023, Page: 587-589, Doi: https://doi.org/10.51248/.v43i02.2370

Abstract

Introduction and Aim: Schizophrenia is a disastrous mental disorder that causes chronic disability. Even after many years of scientific research the underlying pathophysiology of this disorder is unclear. Deficiency of vitamin-B12 and folic acid are associated with many mental disorders. Increase in homocysteine increases risk of several disorders including schizophrenia.
Materials and Methods: Plasma homocysteine, serum vitamin B12 and folic acids were measured in 30 newly diagnosed schizophrenic cases and values were compared with 50 age and sex matched controls.
Results: Plasma homocysteine was significantly increased in schizophrenic cases in comparison to controls, vitamin B12 was significantly decreased in cases in comparison to controls. Increase in homocysteine in cases showed a significant negative correlation with vitamin-B12 of cases.
Conclusion: This study proves an association between increase in homocysteine and decrease in vitamin B12 with schizophrenia.

Keywords: Schizophrenia; homocysteine; vitamin B12; folic acid.

References

1. Jaeschke, K., Hanna, F., Ali, S., Chowdhary, N., Dua, T., Charlson, F. Global estimates of service coverage for severe mental disorders: findings from the WHO Mental Health Atlas 2017. Global Mental Health. 2021;8:e27.

2. El Taweel, E. S.M., ElShafie, T.M., Heba, K. Plasma homocysteine in first-episode schizophrenia: 1-year outcome, a prospective study. Middle East Current Psychiatry. 2018;25(2):42-49.

3. Girdler, S.J., Confino, J.E., Woesner, M.E. Exercise as a treatment for schizophrenia: a review. Psychopharmacology bulletin. 2019;49(1):56-69.

4. http://www.who.int>Newsroom>Fact sheets> Detail> Schizophrenia. [Accessed on :12th Nov 2022]

5. Sagar, R., Dandona, R., Gururaj, G., Dhaliwal, R.S., Singh, A., Ferrari, A. India State-Level Disease Burden Initiative Mental Disorders Collaborators. The burden of mental disorders across the states of India: The Global Burden of Disease Study 1990–2017. Lancet Psychiatry. 2020;7(2):148-161.

6. Wong, A.H.C., Van Tol, H.H. Schizophrenia: from phenomenology to neurobiology. Neuroscience & Biobehavioral Reviews. 2003;27(3):269-306.

7. Pantelis, C., Yücel, M., Wood, S.J., Velakoulis, D., Sun, D., Berger, G., et al., Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophrenia bulletin. 2005;31(3):672-696.

8. Rapoport, J.L., Addington, A.M., Frangou, S., Psych, M.R.C. The neurodevelopmental model of schizophrenia: update 2005. Molecular psychiatry. 2005;10(5):434-449.

9. Osmond, H., Smythies, J. Schizophrenia: a new approach. Journal of Mental Science. 1952;98(411):309-315.

10. Kety, S.S. Biochemical Theories of Schizophrenia: Part II of a two-part critical review of current theories and of the evidence used to support them. Science. 1959;129(3363):1590-1596.

11. Pollin, W., Cardon Jr, P.V., Kety, S.S. Effects of amino acid feedings in schizophrenic patients treated with iproniazid. Science. 1961;133(3446):104-105.

12. Salagre, E., Vizuete, A.F., Leite, M., Brownstein, D.J., McGuinness, A., Jacka, F., et al., Homocysteine as a peripheral biomarker in bipolar disorder: a meta-analysis. European Psychiatry. 2017;43:81-91.

13. Zhou, S.J., Zhang, L.G., Chen, H.M., Li, J.Y., Li, R., Zhang, X.M., et al., Prevalence and clinical-demographic correlates of hyperhomocysteinemia in inpatients with bipolar disorder in a Han Chinese population. Psychiatry research. 2018;259:364-369.

14. Yazici, E., Mutu Pek, T., Guzel, D., Yazici, A.B., Akcay Ciner, O., Erol, A. Klotho, vitamin D and homocysteine levels during acute episode and remission periods in schizophrenia patients. Nordic journal of psychiatry. 2019;73(3):178-184

15. Yu, J., Xue, R., Wang, Q., Yu, H., Liu, X. The Effects of Plasma Homocysteine Level on the Risk of Three Major Psychiatric Disorders: A Mendelian Randomization Study. Frontiers in psychiatry. 2022;13:841429.

16. Kumar, A., Palfrey, H.A., Pathak, R., Kadowitz, P.J., Gettys, T.W., Murthy, S.N. The metabolism and significance of homocysteine in nutrition and health. Nutrition & metabolism. 2017;14(1):1-2.

17. Hermann, A., Sitdikova, G. Homocysteine: Biochemistry, Molecular Biology and Role in Disease. Biomolecules. 2021;11(5):737.

18. Ferrier, D.R., Singh, R., Goyal, R. Lippincott Illustrated Review Biochemistry. SA ed. New Delhi: Wolters Kluwers (India); 2021.

19. Tomioka, Y., Kinoshita, M., Umehara, H., Nakayama, T., Watanabe, S.Y., Nakataki, M., et al., Association between serum folate levels and schizophrenia based on sex. Psychiatry and Clinical Neurosciences. 2020;74(9):466-471.

20. Pedro dos Reis, F., Duarte, L., Cartaxo, T., Santos, V. Folic acid, vitamin B12, and psychotic symptoms among young psychiatric inpatients. Nascer e Crescer-Birth and Growth Medical Journal. 2021;30(2):85-91.

Cite this article

Neelam Mehta, Itishri Jena, Subhashree Ray, Sudeshna Behera, Subrat Kumar Tripathy, Sarthak Ranjan Nayak, Bratati Singh. Plasma homocysteine, serum vitamin B12 and folic acid status in newly detected schizophrenic patients of eastern India. Biomedicine: 2023; 43(2): 587-589

Views
88
Downloads
26
Citations